未诊断心衰患者使用袢利尿剂的结局:回顾性队列研究
英国回顾性倾向匹配队列研究,比较未诊断心衰但使用袢利尿剂者与已诊断心衰者及高危人群的心衰事件复合终点。结果示袢利尿剂组心衰事件率与心衰组相似(71.9% vs 72.1%,HR=0.92,95%CI 0.90–0.94,p<0.001),约为高危组两倍(59.2% vs 35.7%,HR=2.04,95%CI 2.00–2.08,p<0.001),提示部分患者可能存在未诊断心衰。
要点
- 未诊断心衰但用袢利尿剂者心衰事件率与已诊断心衰者相当。
- 该组心衰事件率约为心衰高危人群的两倍。
- 处方袢利尿剂而无心衰诊断时应警惕未诊断心衰。
核心结论
- 未记录心衰诊断但使用袢利尿剂的患者,其心衰事件发生率与已诊断心衰患者相当,提示其中许多可能为未诊断心衰。
主要发现
- 倾向匹配年龄、性别和合并症后,袢利尿剂组与心衰组心衰事件率相似(71.9% vs 72.1%;HR=0.92,95%CI 0.90–0.94;p<0.001)。
- 袢利尿剂组心衰事件率约为高危组两倍(59.2% vs 35.7%;HR=2.04,95%CI 2.00–2.08;p<0.001)。
临床怎么用
- 对社区中处方袢利尿剂但无心衰诊断的患者,应考虑评估是否存在未诊断心衰。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Loop diuretics are commonly prescribed in the community, not always to patients with a recorded diagnosis of heart failure (HF). The rate of HF events in patients prescribed loop diuretics without a diagnosis of HF is unknown. METHODS: This was a propensity-matched cohort study using data from the Clinical Practice Research Datalink, Hospital Episode Statistics and Office of National Statistics in the UK. Patients prescribed a loop diuretic without a diagnosis of HF (loop diuretic group) between 1 January 2010 and 31 December 2015 were compared with patients with HF (HF group)-analysis A, and patients with risk factors for HF (either ischaemic heart disease, or diabetes and hypertension-at-risk group)-analysis B. The primary endpoint was an HF event (a composite of presentation with HF symptoms, HF hospitalisation, HF diagnosis (analysis B only) and all-cause mortality). RESULTS: From a total population of 180 384 patients (78 968 in the loop diuretic group, 28 177 in the HF group and 73 239 in the at-risk group), there were 59 694 patients, 22 352 patients and 57 219 patients in the loop diuretic, HF and at-risk groups, respectively, after exclusion criteria were applied. After propensity matching for age, sex and comorbidities, patients in the loop diuretic group had a similar rate of HF events as those in the HF group (71.9% vs 72.1%; HR=0.92 (95% CI 0.90 to 0.94); p<0.001), and twice as those in the at-risk group (59.2% vs 35.7%; HR=2.04 (95% CI 2.00 to 2.08); p<0.001). CONCLUSIONS: Patients prescribed a loop diuretic without a recorded diagnosis of HF experience HF events at a rate comparable with that of patients with a recorded diagnosis of HF; many of these patients may have undiagnosed HF.
引用
- Cuthbert, Soyiri, Lomax, et al. Outcomes in patients treated with loop diuretics without a diagnosis of heart failure: a retrospective cohort study. Heart. 2024. PMID: 38631899. doi:10.1136/heartjnl-2023-323577
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。